'Confidential Treatment Order - CTO'
Companies would typically seek a CTO in order to keep information that would otherwise put it at a disadvantage, a secret. For example, a company may apply for such an order to keep information regarding a pricing arrangement made with a partner, secret, since competitors finding out this information may go after the partner with a more competitive price.
The CT refers to confidential information that was not provided in the 10-Q filed on November 4, 2013. It is identified as Exhibit 10.1 -
The title to this exhibit in the 10-Q is
Amendment #1 to the Manufacturing Services Agreement, dated February 28, 2013 with an effective date of November 1, 2013, by and between the Registrant and Patheon UK Limited
I am not familiar with this transaction. Perhaps someone can contribute additional information?